Medical devices, healthcare technology and the business of care
510(k) clearance · K260096

Wishbone HAE

Wishbone SA · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONK260096

What did the FDA decide?

FDA recorded decision SESE for 510(k) submission K260096, titled Wishbone HAE, with a decision date of 2026-10-09. The record lists Wishbone SA of Flémalle, Belgium, as applicant and places the submission in the Dental medical specialty under product code NPM. The public notification page shows a received date of 01/13/2026. SESE denotes a substantially equivalent determination, which is a 510(k) clearance rather than premarket approval of a new device.

The available record does not describe the device's components, materials, intended use, or the specific item compared with a predicate, so the technical basis for the equivalence finding is not established here. The relationship between this submission and any earlier filing by the same applicant is also not stated in the retrieved text. Researchers should consult the full FDA decision document for those details.

No clinical performance data, labeling, or postmarket obligations appear in the retrieved material, and none are inferred.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Oct 9, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260096
Regulatory pathway
510(k) premarket notification
Applicant
Wishbone SA
Product code
NPM
Decision code
SESE
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Bone Grafting Material, Animal Source.

Applicant
Wishbone SA
Product code
NPM
FDA device class
2

FDA decision timeline

  1. K260096 received

    Application receipt date recorded by FDA.

  2. K260096 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NPM

Product / regulatory recordCompanyPathwayDecision dateSource
Hyundai Bioland Co., Ltd.510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Wishbone SA

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Flémalle

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records